Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Chief Commercial Officer acquired 12,758 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 114,828 shares (grant or award)
  3. 4 Shares withheld for taxes Chief People Officer gave up 1,912 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,697 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Technology Officer gave up 1,016 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 12,230 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Scientific Officer gave up 417 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Operating Officer gave up 29,578 shares (to pay taxes)
  9. 4 Grant or award Director acquired 22,816 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Chief Operating Officer acquired 1,118 shares (grant or award)
  12. 4 Planned sale President and CEO sold 15,000 shares at $22.93 ($343,950)
  13. 4 Shares withheld for taxes Chief Commercial Officer gave up 8,363 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 452 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Technology Officer gave up 2,515 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,075 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, Chief of Staff gave up 966 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Accounting Officer gave up 964 shares (to pay taxes)
  19. 4 Planned sale President and CEO sold 15,000 shares at $26.72 ($400,800)
  20. 4 Open-market sale Chief Scientific Officer sold 2,100 shares at $26.17 ($54,961)

Page 6 of 65 · 1,293 filings